Skip to main content
. 2015 Feb 8;9(1):2. doi: 10.1186/s40246-015-0024-4

Figure 3.

Figure 3

Signaling pathways in breast cancer with gene mutations. Genetic alterations in breast cancer primarily occur in genes of the MAPK, p53, and PI3K/AKT signaling pathways. Alterations in oncogenes are indicated in pink, and those in cancer suppressor genes are shown in green. Percentages (%) are the frequency of mutations per gene in our study out of 80 samples. Tyrosine kinase receptors (TKRs) include HER2, EGFR, and IGF-1R in breast cancer.